Maximus, Inc. (NYSE:MMS) Shares Purchased by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. grew its stake in shares of Maximus, Inc. (NYSE:MMS) by 45.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 203,561 shares of the health services provider’s stock after purchasing an additional 63,446 shares during the quarter. Assenagon Asset Management S.A. owned approximately 0.36% of Maximus worth $13,881,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also modified their holdings of MMS. Captrust Financial Advisors purchased a new position in Maximus in the 4th quarter valued at $276,000. IFP Advisors Inc raised its stake in Maximus by 62.4% in the 4th quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock valued at $59,000 after purchasing an additional 302 shares during the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of Maximus by 2.4% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 722,172 shares of the health services provider’s stock valued at $54,748,000 after acquiring an additional 16,772 shares during the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of Maximus by 7.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider’s stock valued at $74,700,000 after acquiring an additional 71,598 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in Maximus by 8.2% in the fourth quarter. Bank of New York Mellon Corp now owns 570,740 shares of the health services provider’s stock valued at $42,606,000 after buying an additional 43,421 shares during the period. 97.21% of the stock is owned by institutional investors and hedge funds.

Maximus Stock Performance

Shares of MMS opened at $69.66 on Friday. The business’s fifty day moving average price is $70.45 and its 200 day moving average price is $71.17. Maximus, Inc. has a 12-month low of $63.77 and a 12-month high of $93.97. The stock has a market capitalization of $3.93 billion, a PE ratio of 14.98 and a beta of 0.62. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72.

Maximus (NYSE:MMS) last issued its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.64. The firm had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The firm’s revenue for the quarter was up 1.0% on a year-over-year basis. During the same period last year, the company earned $1.57 earnings per share. Equities research analysts forecast that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Saturday, May 31st. Investors of record on Thursday, May 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.72%. The ex-dividend date of this dividend was Thursday, May 15th. Maximus’s payout ratio is currently 23.86%.

Analysts Set New Price Targets

Separately, Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a report on Thursday, May 15th.

Insider Activity at Maximus

In related news, Director Jan Madsen sold 2,439 shares of the firm’s stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now directly owns 18,097 shares of the company’s stock, valued at approximately $1,225,347.87. This trade represents a 11.88% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gayathri Rajan sold 7,913 shares of the firm’s stock in a transaction that occurred on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director now directly owns 14,205 shares in the company, valued at $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.